📰 Ciences News
Page 118 - Ciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ciences. Real-time updates on events, politics, business and more.
February 13, 2023
- ADORING 1 and 2 trials evaluating VTAMA cream in atopic dermatitis fully enrolled, with topline data expected from the first study in March 2023 and the second study in May 2023 - Dermavant recently
February 13, 2023
To support the ambition and growth of AESARA, a new function within the organization has been created. Ruslan Horblyuk, Chief Strategic Consulting Officer of AESARA, said, "After nearly 5 years at AESARA
February 12, 2023
🔥 Compatibility To confirm that this part fits your vehicle, please enter your vehicles details below. ...<br>
February 11, 2023
Since 2017, GoodRx has helped millions of people find deals on prescription drugs via an app and website. But what its customers may not have known is that the Santa
February 10, 2023
Vancouver, British Columbia--(Newsfile Corp. - February 10, 2023) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a North American Biopharmaceutical company committed to discovering
February 9, 2023
Toronto, Ontario--(Newsfile Corp. - February 8, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with
February 9, 2023
New Professional Network for Female Executives and Specialists to Elevate and Promote Female Talents across the Life Sciences industry in Denmark Supported by the Novo Nordisk Foundation
February 9, 2023
EVOTEC AND RELATED SCIENCES COLLABORATE BY COMBINING COMPLEMENTARY CAPABILITIES TO ADVANCE PORTFOLIOS OF TRANSFORMATIONAL NEW MEDICINESTHE PARTNERSHIP OVERSEES A GROWING PORTFOLIO OF MORE THAN 15 MULTI-MODALITY
February 9, 2023
-- In Three-Year Follow-up in Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia, Tecartus Shows High Rates of Durable Response (CR+CRi 71%) and a Median Overall Survival of 26 Months
February 9, 2023
Toronto, Ontario--(Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with